CNS
Specialist expertise in in vivo and ex vivo neurochemistry and neurobehaviour. Pharmidex can provide PK, PD, target engagement and efficacy information for novel therapeutic agents in development.
Extensive experience supporting the progression of candidate drugs for the treatment of neurodegenerative and psychiatric disorders, such as Alzheimer’s and Parkinson’s disease, schizophrenia or depression.
Pharmidex is committed to supporting industry and academic partners in their search for developing safer and more efficacious CNS treatments.
We currently offer a range of techniques to support the progression of CNS drug candidates.
Neurochemistry
Bioanalysis
LC-MS/MS
ELISA
Luminex
BBB assessment
Animal Models
Neurobehaviour
+44 (0) 870 240 5978
For any enquires regarding our services please email [email protected]
Copyright © 2024 Pharmidex All rights reserved. Privacy Policy | Terms & Conditions